Tumor markers currently utilized in cancer care

Jin Woo Lee, Bon Seok Koo, The prognostic implication and potential role of BRAF mutation in the decision to perform elective neck dissection for thyroid cancer. Gland surgery. ,vol. 2, pp. 206- 211 ,(2013) , 10.3978/J.ISSN.2227-684X.2013.11.02

Sami Malek, Molecular Biomarkers in Chronic Lymphocytic Leukemia Advances in Experimental Medicine and Biology. ,vol. 792, pp. 193- 214 ,(2013) , 10.1007/978-1-4614-8051-8_9

Ramon Andrade de Mello, Andrea Marin Marques, António Araújo, None, HER2 therapies and gastric cancer: A step forward World Journal of Gastroenterology. ,vol. 19, pp. 6165- 6169 ,(2013) , 10.3748/WJG.V19.I37.6165

Mai Brooks, Breast cancer screening and biomarkers. Methods of Molecular Biology. ,vol. 472, pp. 307- 321 ,(2009) , 10.1007/978-1-60327-492-0_13

Pavithra Venkanteshan, Kasturi Kondapalli, Mallika Siva Donepudi, Seelam Jeevan Amos, Breast cancer statistics and markers Journal of Cancer Research and Therapeutics. ,vol. 10, pp. 506- 511 ,(2014) , 10.4103/0973-1482.137927

An He, Tian-Cai Liu, Zhi-Ning Dong, Zhi-Qi Ren, Jing-Yuan Hou, Ming Li, Ying-Song Wu, A novel immunoassay for the quantization of CYFRA 21-1 in human serum. Journal of Clinical Laboratory Analysis. ,vol. 27, pp. 277- 283 ,(2013) , 10.1002/JCLA.21597

Muaiad Kittaneh, Alberto J. Montero, Stefan Glück, Molecular profiling for breast cancer: a comprehensive review. Biomarkers in Cancer. ,vol. 5, pp. 61- 70 ,(2013) , 10.4137/BIC.S9455

Ali Mazloom, L. Jeffrey Medeiros, Peter W. McLaughlin, Valerie Reed, Fernando F. Cabanillas, Luis E. Fayad, Barbara Pro, Graciela Gonzalez, Puneeth Iyengar, Diana L. Urbauer, Bouthaina S. Dabaja, Marginal zone lymphomas: factors that affect the final outcome. Cancer. ,vol. 116, pp. 4291- 4298 ,(2010) , 10.1002/CNCR.25325

Vincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, Elisa Carretta, Lorena Rossi, Emanuela Bianchi, Carla Masini, Dino Amadori, Ugo De Giorgi, Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide. The Prostate. ,vol. 74, pp. 1691- 1696 ,(2014) , 10.1002/PROS.22890

Morie A. Gertz, Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management. American Journal of Hematology. ,vol. 88, pp. 703- 711 ,(2013) , 10.1002/AJH.23472